CNS and Neurological Disorders - Drug Targets
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 58.4% | 0.789 | Q2 | 76.8% |
| 2024 | 3.0 | Q2 | 61.2% | 0.710 | Q2 | 74.0% |
| 2023 | 2.7 | Q2 | 54.1% | 0.620 | Q2 | 72.0% |
| 2022 | 3.0 | Q3 | 53.3% | 0.574 | Q2 | 70.6% |
| 2021 | 2.8 | Q3 | 47.4% | 0.561 | Q2 | 70.7% |
| 2020 | — | — | 0.923 | Q2 | 83.4% | |
| 2019 | — | — | 0.832 | Q2 | 81.3% | |
| 2018 | — | — | 0.747 | Q2 | 76.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1996-3181
ISSN
1871-5273
country
AEcoverage
2006-2026